These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29607937)

  • 1. Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice.
    Kuritani M; Sakai N; Karakawa A; Isawa M; Chatani M; Negishi-Koga T; Funatsu T; Takami M
    Biol Pharm Bull; 2018; 41(4):637-643. PubMed ID: 29607937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory, anti-osteoclastic, and antioxidant activities of genistein protect against alveolar bone loss and periodontal tissue degradation in a mouse model of periodontitis.
    Bhattarai G; Poudel SB; Kook SH; Lee JC
    J Biomed Mater Res A; 2017 Sep; 105(9):2510-2521. PubMed ID: 28509410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.
    Williams DW; Lee C; Kim T; Yagita H; Wu H; Park S; Yang P; Liu H; Shi S; Shin KH; Kang MK; Park NH; Kim RH
    Am J Pathol; 2014 Nov; 184(11):3084-93. PubMed ID: 25173134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model.
    Kimura K; Kitaura H; Fujii T; Ishida M; Hakami ZW; Takano-Yamamoto T
    Oral Dis; 2014 Apr; 20(3):319-24. PubMed ID: 23651419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice.
    Zhang Z; Song J; Kwon SH; Wang Z; Park SG; Piao X; Ryu JH; Kim N; Kim OS; Kim SH; Koh JT
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
    Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
    J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of neutrophils causes RANKL expression in periodontal tissue, giving rise to osteoclast formation.
    Kim AR; Kim JH; Choi YH; Jeon YE; Cha JH; Bak EJ; Yoo YJ
    J Periodontal Res; 2020 Dec; 55(6):868-876. PubMed ID: 32583887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell c1 and carbonic anhydrase 2.
    Nakagawa T; Ohta K; Kubozono K; Ishida Y; Naruse T; Takechi M; Kamata N
    Arch Oral Biol; 2015 Apr; 60(4):557-65. PubMed ID: 25601046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myricetin Prevents Alveolar Bone Loss in an Experimental Ovariectomized Mouse Model of Periodontitis.
    Huang J; Wu C; Tian B; Zhou X; Ma N; Qian Y
    Int J Mol Sci; 2016 Mar; 17(3):422. PubMed ID: 27011174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boldine inhibits the alveolar bone resorption during ligature-induced periodontitis by modulating the Th17/Treg imbalance.
    Cafferata EA; Castro-Saavedra S; Fuentes-Barros G; Melgar-Rodríguez S; Rivera F; Carvajal P; Hernández M; Cortés BI; Cortez C; Cassels BK; Vernal R
    J Periodontol; 2021 Jan; 92(1):123-136. PubMed ID: 32490537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved RANKL production by memory B cells: A way for B cells promote alveolar bone destruction during periodontitis.
    Han YK; Jin Y; Miao YB; Shi T; Lin XP
    Int Immunopharmacol; 2018 Nov; 64():232-237. PubMed ID: 30199848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats.
    Sağlam M; Köseoğlu S; Hatipoğlu M; Esen HH; Köksal E
    J Appl Oral Sci; 2015; 23(1):33-41. PubMed ID: 25760266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo.
    Ihn HJ; Lee T; Kim JA; Lee D; Kim ND; Shin HI; Bae YC; Park EK
    PLoS One; 2017; 12(1):e0170159. PubMed ID: 28085946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Shogaol, an active ingredient of ginger, inhibits osteoclastogenesis and alveolar bone resorption in ligature-induced periodontitis in mice.
    Kim YG; Kim MO; Kim SH; Kim HJ; Pokhrel NK; Lee JH; Lee HJ; Kim JY; Lee Y
    J Periodontol; 2020 Jun; 91(6):809-818. PubMed ID: 31675438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin decreases bone loss and collagen destruction in rats with ligature-induced periodontitis.
    Yang X; Zhang H; Wang J; Zhang Z; Li C
    J Periodontal Res; 2015 Dec; 50(6):748-57. PubMed ID: 25645818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene reduces the risk of local alveolar bone destruction in a mouse model of periodontitis combined with systemic postmenopausal osteoporosis.
    Ichimaru R; Tominari T; Yoshinouchi S; Matsumoto C; Watanabe K; Hirata M; Numabe Y; Murphy G; Nagase H; Miyaura C; Inada M
    Arch Oral Biol; 2018 Jan; 85():98-103. PubMed ID: 29035723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor activator of nuclear factor-κB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis.
    Kim JH; Lee DE; Cha JH; Bak EJ; Yoo YJ
    J Periodontol; 2014 Nov; 85(11):e370-8. PubMed ID: 25070541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan.
    Yasuda H
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(4):209-16. PubMed ID: 23994799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.